deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT02787642

A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma (RADIOSARP)

A Phase Ib Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma

Sponsor: Institut Bergonié

Conditions Soft-tissue Sarcoma
Interventions Concomitant Radiotherapy Olaparib
Updated 11 times since 2017 Last updated: Feb 6, 2026 Started: Jan 31, 2016 Primary completion: Oct 31, 2021 Completion: May 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Soft-tissue Sarcoma and is currently completed. Institut Bergonié leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotNot Yet Recruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotRecruiting~Oct 2018 – ~Mar 2020 · 17 months · monthly snapshotRecruiting~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotRecruiting~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshotRecruiting~Jun 2021 – ~Apr 2023 · 22 months · monthly snapshotRecruiting~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotCompleted~Feb 2026 – present · 7 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Feb 2026 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Apr 2023 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  5. Jun 2021 — Apr 2023 [monthly]

    Recruiting PHASE1

▶ Show 6 earlier versions

  1. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE1

  2. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  3. Oct 2018 — Mar 2020 [monthly]

    Recruiting PHASE1

  4. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE1

  5. Sep 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  6. Jan 2017 — Sep 2017 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut Bergonié
  • National Cancer Institute, France
Data source: Institut Bergonié

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations